Can an externally validated model identify patients at risk for adverse events and poor symptom improvement after TAVI?
An externally validated predictive model can identify patients at risk for poor clinical and symptomatic outcomes following TAVI.
Our externally validated model can reasonably identify patients with both poor symptom improvement and adverse events after TAVI.
Bergeijk et al. (Mon,) studied this question.